Lion's Mane Dosing on Attention and Mood
ConditionAttention
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorNorthumbria University
About this trial
The primary purpose of the research is to evaluate in healthy adults the time course effects of varying dosages of Lion's mane mushroom on attention and mood.
Eligibility criteria
Qualifiers
Participants must self-assess themselves as being in good health
Participants must be aged 18 to 45 at the time of giving consent
Understand and are willing to participate in all scheduled visits and to adhere to the trial procedures outlined in the subject information sheet
Are fluent in English (equivalent to IELTS Level 6)
Disqualifiers
Have any pre-existing medical condition/illness which will impact taking part in the study. There may be other, unforeseen, exceptions and these will be considered on a case-by-case basis, i.e., participants may be allowed to progress to screening if they have a condition/illness which would not interact with the active treatments or impede performance so it's worth discussing any medical conditions with the researcher prior to booking lab appointments. NOTE: the explicit exceptions to this is controlled hayfever, asthma, hypo/hyperthyroidism, high blood pressure, high cholesterol, reflux.
Are currently taking prescription medications NOTE: the explicit exceptions to this are contraceptive treatments, and those taken 'as needed' in the treatment of asthma and hay fever. There may be other instances of medication use which, where no interaction with the active treatments is likely, and which would not be expected to have any impact on brain function, participants may be able to progress to screening.
Have a history of experiencing difficulty swallowing tablets including in capsule form
Have high blood pressure (systolic over 139 mm Hg or diastolic over 89 mm Hg)
Trial design
Treatments tested in this trial
- Lion's Mane fruiting bodies extract
- Placebo
Treatment groups
24 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov